New Research Poster Presentation 2.56 A Double-Blind, Placebo-Controlled Trial of Atomoxetine Once Daily for 24 Weeks in Adults with ADHD: Impact of Treatment on Family Functioning
Thursday, October 28, 2010
Linda Wietecha, M.S., R.N., Lilly USA, LLC, Indianapolis, IN
Meihua Qiao, Ph.D., Eli Lilly and Company, Indianapolis, IN
David W. Dunn, M.D., Riley Hospital, Indianapolis, IN
Joel L. Young, M.D., Rochester Center for Behavioral Medicine, Rochester Hills, MI
Keith Saylor, Ph.D., Sc.M., NeuroScience, Inc., Herndon, VA